| Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042) |
|---|
| 02/09/2006 | WO2006014907A2 Use of parasitic biological agents for prevention and control of allergic and other ige-mediated disorders |
| 02/09/2006 | WO2006014642A1 Method of producing autologous embryonic stem cells |
| 02/09/2006 | WO2006013003A1 Use of products derived from selenoprotein t, in its application related to calcium homeostasis |
| 02/09/2006 | WO2005108617A3 Mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 02/09/2006 | WO2005077022A3 Compositions and methods for modifying the content of polyunsaturated fatty acids in biological cells |
| 02/09/2006 | WO2005070044A3 Systems and methods for short rna expression |
| 02/09/2006 | WO2004056983A3 Metalloprotease proteins |
| 02/09/2006 | WO2002097110A3 TUMOR ENDOTHELIAL MARKER 7α MOLECULES AND USES THEREOF |
| 02/09/2006 | US20060031956 Nucleotide sequences for gene regulation and methods of use thereof |
| 02/09/2006 | US20060031955 Novel culture systems for EX vivo development |
| 02/09/2006 | US20060031954 FcRn-based therapeutics for the treatment of auto-immune disorders |
| 02/09/2006 | US20060031953 Production of dual models of Congenital Heart Defects and Hypertrophic Cardiomyopathy with the use of mice which are genetically modified by transgenic (gene-knockout) techniques; cardiovascular disorders |
| 02/09/2006 | US20060031952 Methods for producing transgenic animals |
| 02/09/2006 | US20060031951 Improved modalities for the treatment of degenerative diseases of the retina |
| 02/09/2006 | US20060031950 Non-mammalian transgenic animal model for cellular proliferative diseases |
| 02/09/2006 | US20060031949 Inducible expression systems for modulating the expression of target genes in eukaryotic cells and non-human animals |
| 02/09/2006 | US20060031948 Inducible expression systems for modulating the expression of target genes in eukaryotic cells and non-human animals |
| 02/09/2006 | US20060031947 Novel mutated mammalian cells and animals |
| 02/09/2006 | US20060031946 Gene therapy with chimeric oligonucleotides delivered by a method comprising a step of iontophoresis |
| 02/09/2006 | US20060031945 Inducible expression systems for modulating the expression of target genes in eukaryotic cells and non-human animals |
| 02/09/2006 | US20060031944 Embryonic stem cells capable of differentiating into desired cell lines |
| 02/09/2006 | US20060030540 Transgenic animals produced using oral administration of a genetic agent coupled to a transporting agent |
| 02/09/2006 | US20060030005 C3b/C4b complement receptor-like molecules and uses thereof |
| 02/09/2006 | US20060030002 Isoforms of the human Vitamin D receptor |
| 02/09/2006 | US20060029588 Lysyl oxidase-like 1 (LOXL1) and elastogenesis |
| 02/09/2006 | US20060027172 Method and housing assembly for farming members of the phylum arthropoda |
| 02/08/2006 | EP1624304A1 Probe for detecting and quantifying lipid second messenger and method of detecting and quantifying lipid second messenger using the same |
| 02/08/2006 | EP1624060A2 Control of gene expression |
| 02/08/2006 | EP1381271B1 Automatic system-based animal training device |
| 02/08/2006 | EP1155148B1 Detection and quantification of micro-organisms using amplification and restriction enzyme analysis |
| 02/08/2006 | EP1112362B1 GENE MODIFICATION IN THE GENE FOR THE DIE G$g(b)3-SUB-UNIT OF HUMAN G-PROTEIN |
| 02/08/2006 | EP1108058B1 Evolution of whole cells and organisms by recursive sequence recombination |
| 02/08/2006 | EP0812356B1 Prostate-specific membrane antigen and uses thereof |
| 02/08/2006 | EP0765391B1 Cloning and expression of an acetylcholine-gated ion channel receptor subunit |
| 02/08/2006 | EP0687296B1 Variants of bile salt-stimulated lipase, dna molecules encoding them, and transgenic non-human mammals |
| 02/08/2006 | CN2755976Y Ant culture box |
| 02/08/2006 | CN1731932A Methods of diagnosis and treatment of interstitial lung disease |
| 02/08/2006 | CN1730659A Method for preparing mammal galactophore biological reactor using gene targeting technology |
| 02/08/2006 | CN1729767A Method for artificial copulating prawn by sperm transplantation |
| 02/08/2006 | CN1729766A Complete artificial method for breeding Ciona and simple continuous bait scattering device |
| 02/08/2006 | CN1241008C Milking device for laboratory animals |
| 02/08/2006 | CN1240273C Method for preventing and treating aphid by artificial baiting eleven-star ladybug |
| 02/08/2006 | CN1240272C In OVO activation of an avian egg in the shell and method for fertilizing avian egg inside shell |
| 02/07/2006 | US6995299 Model system for Hepatitis C virus infection in humans, comprising non-human animal rendered immunologically tolerant to human hepatocytes and subsequently transplanted with human hepatocytes and infected with Hepatitis C |
| 02/07/2006 | US6995298 rodents which expresses transgenes integrated into its genome, wherein the genes comprises DNA codes for proteins having amino acid replacements so that the mammal has platelets with reduced or absent phosphorylation; genetic engineering |
| 02/07/2006 | US6995011 Expression vector for use as tool in gene therapy |
| 02/07/2006 | US6994957 Using nucleic acid |
| 02/02/2006 | WO2006012177A2 Method to decrease the rate of polyspermy in ivf |
| 02/02/2006 | WO2006011491A1 Plasmid vector, transgenic animal, method of screening drug and drug |
| 02/02/2006 | WO2005120222A3 Genetically modified non-human mammals and cells |
| 02/02/2006 | US20060026703 Transgenic non-human animals for producing heterologous and chimeric antibodies |
| 02/02/2006 | US20060026702 Phosphoinositide 3-kinase mediated inhibition of GPCRs |
| 02/02/2006 | US20060026701 Human albumin animal models for drug evaluation, Toxicology and immunogenicity studies |
| 02/02/2006 | US20060026700 Tissue specific genes and gene clusters |
| 02/02/2006 | US20060026699 Methods and compositions for identification of genomic sequences |
| 02/02/2006 | US20060026698 Transgenic transchromosomal rodents for making human antibodies |
| 02/02/2006 | US20060026697 Genetic immunization of transgenic animals with non-eukaryotic expression systems |
| 02/02/2006 | US20060026696 Humanized immunoglobulin loci |
| 02/02/2006 | US20060026695 Transgenically produced fusion proteins |
| 02/02/2006 | US20060026694 Method for generating immune-compatible cells and tissues using nuclear transfer techniques |
| 02/02/2006 | US20060025582 Promoter sequences for corticotropin releasing-factor receptor CRF2alpha and method of identifying agents that alter the activity of the promoter sequences |
| 02/02/2006 | US20060025397 Method of resistance of epilepsy by suppressing the function of alpha 1g protein |
| 02/02/2006 | US20060024820 Chromosome-based platforms |
| 02/02/2006 | US20060024800 Method of modulating the activity of functional immune molecules |
| 02/02/2006 | US20060024795 Interferon-Like molecules and uses thereof |
| 02/02/2006 | US20060024788 Inducible alphaviral gene expression system |
| 02/02/2006 | US20060024688 Alterations of fibulin genes in macular degeneration |
| 02/02/2006 | US20060024662 Methods for magnetic resonance imaging |
| 02/02/2006 | US20060024333 Use of parasitic biological agents for prevention and control of allergic and other IgE-mediated disorders |
| 02/02/2006 | US20060024280 Stem cell-derived endothelial cells modified to disrupt tumor angiogenesis |
| 02/02/2006 | US20060024267 TNFr/OPG-like molecules and uses thereof |
| 02/02/2006 | CA2575683A1 Chn-1/chip-antagonists for the treatment of muscular diseases |
| 02/01/2006 | EP1621621A1 Human 7tm protein receptors and polynucleotides encoding the same |
| 02/01/2006 | EP1621204A1 Use of products derived from selenoprotein T in the context of calcium homeostasis |
| 02/01/2006 | EP1620112A2 Desmoglein 4 is a novel gene involved in hair growth |
| 02/01/2006 | EP1461052A4 Nucleic acid injected into hepatic vein lumen and delivered to primate liver |
| 02/01/2006 | CN1729298A Modified antibodies stably produced in milk and methods of producing same |
| 02/01/2006 | CN1729201A Isolated fluorescent protein from clytia gregaria CGFP and use thereof |
| 02/01/2006 | CN1726771A Method for hatching serpentes |
| 02/01/2006 | CN1726770A Technique of no winter sleep for breeding serpentes |
| 02/01/2006 | CN1240259C Method for forming holes, using flexible connection board formed thereof and its producing method |
| 01/31/2006 | US6992235 Method for marker-free repetitive DNA expression cassette exchange in the genome of cells or parts of cells |
| 01/31/2006 | US6991936 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 01/31/2006 | US6991920 Peptide for use in human therapeutics and diagnostics |
| 01/30/2006 | CA2510809A1 Chimpanzee trace amine associated receptors |
| 01/26/2006 | WO2006009903A2 High throughput cancer pharmaceutical screening using drosophila |
| 01/26/2006 | WO2006009814A2 Products and methods related to mono-methyl branched-chain fatty acids |
| 01/26/2006 | WO2006009297A1 Construction of chimera using es cells |
| 01/26/2006 | WO2006008548A2 Binding molecules |
| 01/26/2006 | WO2006008484A2 Detection of cellular stress |
| 01/26/2006 | WO2006008142A1 Diagnosis and therapy of psoriasis vulgaris |
| 01/26/2006 | WO2005110076A3 Braf expression in zebrafish and uses thereof |
| 01/26/2006 | US20060021075 Group 1 CD1 transgenic mice and their uses |
| 01/26/2006 | US20060021074 Reducing the risk of human anti-human antibodies through V gene manipulation |
| 01/26/2006 | US20060021073 Noc2 knockout mouse |
| 01/26/2006 | US20060021072 Mouse model for type II diabetes |
| 01/26/2006 | US20060021071 Cell in which genome is modified |
| 01/26/2006 | US20060021070 Production of chimeric bovine or porcine animals using cultured inner cell mass |
| 01/26/2006 | US20060021069 Antibody production methods related to disruption of peripheral tolerance in B lymphocytes |
| 01/26/2006 | US20060019897 Anti-angiogenic polypeptides |